查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1835109

事后紧急避孕药市场（按产品类型、配方类型和年龄划分）—2025-2032 年全球预测

Emergency Contraceptive Pills Market by Product Type, Prescription Type, Age Group - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

事后紧急避孕药市场预计到 2032 年将成长至 18.2 亿美元，复合年增长率为 6.64%。

主要市场统计数据
基准年2024年 10.8亿美元
预计2025年 11.6亿美元
预测年份：2032年 18.2亿美元
复合年增长率（%） 6.64%

简要介绍影响事后紧急避孕药取得和交付的当代临床、监管和消费者力量。

影响事后紧急避孕药的新动态来自临床、监管和消费者主导。药理学的进步和不断发展的临床指南正在改变这些产品在临床和零售通路的定位。同时，监管机构和公共卫生部门持续调整取得途径，包括非商店药和远端医疗辅助配药，扩大了提供时效性照护的机制范围。

随着数位健康平台、消费者教育宣传活动以及日益增长的生殖自主意识影响需求模式，消费行为也在改变。这种转变也伴随着供给面的转型。製造商正在调整配方、包装和分销管道，以满足快速获取的期望，同时克服采购和製造方面的限制。在接下来的周期中，相关人员必须在实证临床讯息和切实可行的获取解决方案之间取得平衡，以确保安全及时地使用，并减轻延迟治疗的耻辱感。

监管变化、远端医疗的扩展和数位商务将如何改变事后紧急避孕药的取得、分销和竞争定位

由于监管调整、医疗途径数位化以及消费者期望的变化，事后紧急避孕药格局正在转变。监管机构正在逐步修订非处方药框架和标籤，以扩大安全取得管道。同时，许多医疗系统正在整合远距远端医疗途径，以缩短治疗时间并在必要时维持临床监测。同时，网路药局和零售连锁店正在打造无缝的购买和履约体验，在加速消费者取得药品的同时，又不影响咨询或安全保障。

在供应方面，配方创新和包装重新设计正着眼于以用户为中心的特性，以减少剂量错误并提高谨慎的可及性。这一转变促使老牌和新进者製造商重新定位竞争，优先考虑快速上架和全通路分销。因此，监管敏捷性、与数位管道的协作以及临床营运、商业化和供应链团队之间的跨职能协作已成为在保障患者安全的同时抓住新商机的战略要务。

评估 2025 年关税转变如何增强事后紧急避孕药产品管道的供应链重组、采购多样化和成本管理。

有关关税实施的政策决定将对医药供应链、筹资策略和产品定价动态产生实际的下游影响。 2025年的关税给进口活性药物原料药和最终产品带来了额外的成本压力，迫使买家和製造商重新评估筹资策略。为此，一些製造商加快了替代供应商的资格审查或转移了生产基地，以尽量减少进口关税的影响，而另一些製造商则吸收了增加的成本，以保持在敏感治疗类别的零售竞争力。

这些调整导致供应链透明度和合约弹性日益受到重视。采购团队越来越重视多源供应商网路以及内建紧急条款的长期供应商关係。同时，监控监管和贸易政策已成为商业规划团队的核心能力，因为关税波动会影响库存政策和跨境分销协议。总体而言，2025年关税的累积影响引发了垂直整合、近岸外包讨论的增加，以及对製造和分销节点成本管理的更多关注。

深入洞察揭示产品类型、配方和年龄层如何影响紧急避孕药的取得、通讯和管道策略

深刻的市场细分揭示了差异化的需求驱动因素和获取途径，需要客製化的策略回应。按产品类型划分，levonorgestrel、米非司酮和醋酸乌利司他之间的市场动态在临床适应症、给药持续时间和监管状态方面有所不同，这会影响标籤检视、消费者指导和分销选择。按处方笺类型划分，OTC 和处方笺之间的差异决定了通路策略、患者咨询要求和付款人互动。

按年龄细分也有助于精准推广和包装：在各个年龄层中，15-19岁、20-24岁、25-29岁和30岁以上的人群拥有不同的健康素养、购买偏好和隐私期望。年轻族群倾向于选择数位优先的资讯管道和谨慎的履约方式，而老年人则可能更倾向于面对面的临床咨询和丰富的产品资讯。这些细分视角为产品经理和病人参与团队提供了一个实用的框架，使他们能够根据临床限制和消费行为，设计差异化的行销方案、教育材料和经销伙伴关係。

比较区​​域观点突显了法律规范、文化规范和製造足迹如何推动世界各地不同的获取和分销策略

区域动态正在显着不同地塑造监管方法、供应链架构和消费者获取模式。在美洲，政策讨论和倡导正在推动透过非处方药和远端医疗服务相结合的方式扩大获取途径，从而形成了由成熟分销网络支持的强劲零售和电商管道。相较之下，欧洲、中东和非洲的监管格局复杂多样，取得途径因国家政策、文化规范和报销制度而异，需要製定量身定制的监管策略和相关人员参与计画。

亚太地区兼具高产量製造能力和快速发展的数位医疗应用，使其成为重要的製造中心和充满活力的消费分销创新市场。这些地区差异需要差异化的商业性策略，而监管投入、本地伙伴关係以及文化契合的沟通对于应对政策差异并优化跨司法管辖区的产品定位至关重要。

竞争对手的行动和策略重点：製造商、学名药和数位参与企业如何塑造产品取得和分销生态系统

活跃于事后紧急避孕药的主要企业正在推行反映产品组合深度、通路覆盖和製造能力的策略。现有的製药商正在利用其规模、监管经验以及与批发商的传统关係来维持广泛的分销管道，而学名药製造商则专注于成本效益和在监管途径允许的情况下快速推出产品。新兴企业，包括专业生物技术和数位健康平台，正专注于差异化服务模式，将远端医疗与整合式履约和消费者教育相结合。

各类公司都采取了不同的策略倡议，包括投资配方改进、与连锁药局和线上平台合作，以及选择性地扩大区域产能以降低贸易相关风险。重视临床、监管和商业部门之间跨职能协调的公司，往往会加快产品上市速度，从而实现标籤更新和通路转型。竞争优势日益依赖在合规性、快速取得和以消费者为中心的设计之间取得平衡的能力，同时透过营运效率和供应链韧性来保障净利率。

建议领导者采取行动，以增强供应弹性、扩大数位访问，并使监管策略与以消费者为中心的商品销售保持一致。

产业领导者应采取切实可行的措施，平衡医疗服务的可近性、安全性和商业性永续性。首先，应实现供应网络多元化，并投资于来源资格认证，以降低单一来源风险，而贸易政策波动会加剧这种风险。其次，应将远端保健伙伴关係和数位商务能力整合到全通路策略中，以确保及时取得医疗服务，并涵盖那些重视隐私和便利性的群体。

第三，将监管工作与商业计划相结合，加快标籤澄清和临床适用的非处方药（OTC）转换，同时确保产品标籤检视和包装符合实际使用要求。第四，投资进行针对不同人群和临床受众的有针对性的教育宣传活动，以减少滥用并缩短治疗时间。最后，实施先进的库存和需求感知，以便在政策主导的供应中断期间保持服务水平，并将情境规划纳入策略评估，以快速应对不断变化的贸易和监管环境。

透明的调查方法概述：描述用于得出见解和策略意义的证据来源、相关人员咨询和情境主导分析

该分析整合了监管备案文件、临床指南更新、供应链趋势报告和公开发布的政策公告，以形成切实可行的洞察。主要资讯包括监管决策和指导文件、贸易政策通知以及对供应链和商业行业领导者的匿名行业访谈，以指导分销和筹资策略。次要资讯包括同侪审查的疗效指标和安全性临床文献，以及总结的数位健康应用指标，以反映患者获取管道的变化。

此分析方法结合了定性综合分析和情境影响评估，以评估政策转变、供应链中断和管道演变的影响。透过比较独立资讯来源与执业者的观点进行交叉验证，以确保一致性并发现需要密切监控的差距。伦理考量和病人安全始终贯穿整个调查方法的核心，并将临床证据与权威指导文件进行交叉核对，以确保准确性和有效性。

结论性综合强调，弹性、监管完整性和以病人为中心的策略是可靠的事后紧急避孕药的支柱

事后紧急避孕药的独特之处在于其处于临床紧迫性、政策敏感性和消费者偏好的交汇点，这为相关人员创造了机会，也带来了责任。随着法律规范和数位管道的不断发展，最成功的组织将是那些能够快速将临床证据转化为安全获取途径，同时保持供应链稳健性和文化契合度沟通的组织。贸易政策、製造地和分销网络之间的相互作用凸显了采购灵活性的重要性，以及在不断变化的环境下维持本地伙伴关係关係的价值。

展望未来，决策者应优先考虑监管、商业和临床领域之间的互通性，以快速应对不断变化的政策和公共卫生指导。注重弹性、以消费者为中心的设计和监管协调，将使相关人员能够负责任地扩大紧急避孕措施的可近性，同时保障产品品质和病患治疗效果。现在做出的策略选择将决定谁能在快速变化和公众担忧日益加剧的环境下，可靠地提供及时安全的紧急避孕措施。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 远端医疗平台在全国扩展处方笺和送货上门服务
  • Z 世代社群媒体活动旨在提高大众对事后紧急避孕药的认识并促进其普及
  • 多布斯法案之后的政策变化影响了非处方事后紧急避孕药的供应和价格
  • 将事后紧急避孕药整合到数位健康应用程式中，并提供个人化的性交后指导
  • 对荷尔蒙残留日益增长的环境担忧推动环保包装的创新
  • 亚马逊药房和线上零售商的电子商务渗透推动了按需药丸购买

第六章 2025年美国关税的累积影响

第七章 人工智慧的累积影响，2025年

第八章事后紧急避孕药市场（依产品类型）

  • levonorgestrel
  • 米非司酮
  • 醋酸乌利司他

第九章事后紧急避孕药市场（依处方类型）

  • 非处方药
  • 处方笺

第 10 章事后紧急避孕药市场（依年龄层）

  • 15至19岁
  • 20-24岁
  • 25-29岁
  • 30岁或以上

第十一章事后紧急避孕药市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十二章事后紧急避孕药市场（按类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十三章事后紧急避孕药市场（按国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十四章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Bayer AG
    • Teva Pharmaceutical Industries Ltd
    • Viatris Inc
    • Cipla Ltd
    • Dr. Reddy's Laboratories Ltd
    • Lupin Ltd
    • Sandoz International GmbH
    • Perrigo Company plc
    • Glenmark Pharmaceuticals Ltd
    • Apotex Inc
Product Code: MRR-43798151BF31

The Emergency Contraceptive Pills Market is projected to grow by USD 1.82 billion at a CAGR of 6.64% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.08 billion
Estimated Year [2025] USD 1.16 billion
Forecast Year [2032] USD 1.82 billion
CAGR (%) 6.64%

A succinct introduction to contemporary clinical, regulatory, and consumer forces reshaping access and delivery of emergency contraceptive pills

The emergent dynamics shaping emergency contraceptive pills are simultaneously clinical, regulatory, and consumer-driven. Advances in pharmacology and evolving clinical guidelines have altered how these products are positioned in clinical practice and retail channels. At the same time, regulatory agencies and public health authorities continue to adjust access pathways, including over-the-counter availability and telehealth-enabled prescribing, which has broadened the range of delivery mechanisms for time-sensitive care.

Consumer behavior is also shifting, as digital health platforms, consumer education campaigns, and greater awareness of reproductive autonomy influence demand patterns. This transition is accompanied by supply-side transformations: manufacturers are adapting formulations, packaging, and distribution to meet rapid-access expectations while navigating procurement and manufacturing constraints. In the coming cycles, stakeholders must balance evidence-based clinical messaging with pragmatic access solutions to ensure safe, timely use and to mitigate stigma that can delay care.

How regulatory shifts, telehealth expansion, and digital commerce are jointly transforming access, distribution, and competitive positioning for emergency contraceptive pills

The landscape for emergency contraceptive pills has experienced transformative shifts driven by regulatory recalibration, digitization of care pathways, and changes in consumer expectations. Regulatory authorities progressively reassess over-the-counter frameworks and labeling to expand safe access, while many health systems are integrating telemedicine pathways to shorten time-to-treatment and preserve clinical oversight where needed. Simultaneously, e-pharmacies and retail chains are creating seamless purchase and fulfillment experiences that accelerate consumer access without compromising counseling and safety safeguards.

On the supply side, formulation innovation and packaging redesigns focus on user-centric features that reduce administration errors and improve discreet access. These transformations have catalyzed competitive repositioning among established manufacturers and newer entrants that prioritize speed-to-shelf and omnichannel distribution. As a result, strategic imperatives now center on regulatory agility, digital channel partnerships, and cross-functional alignment between clinical affairs, commercialization, and supply chain teams to capture emerging opportunities while maintaining patient safety.

Assessing how tariff policy shifts in 2025 intensified supply chain reconfiguration, sourcing diversification, and cost management across emergency contraceptive product channels

Policy decisions regarding tariff implementation have tangible downstream effects on pharmaceutical supply chains, procurement strategies, and product pricing dynamics. Tariffs imposed in 2025 introduced additional cost pressures on imported active pharmaceutical ingredients and finished products, prompting buyers and manufacturers to reassess sourcing strategies. In response, some manufacturers accelerated qualification of alternative suppliers or shifted production footprints to minimize exposure to import duties, while others absorbed incremental costs to preserve retail competitiveness in sensitive therapeutic categories.

These adjustments have emphasized the value of supply chain transparency and contractual agility. Procurement teams increasingly prioritize multi-sourced supplier networks and longer-term supplier relationships that incorporate contingency clauses. Meanwhile, regulatory and trade policy monitoring has become a core competency for commercial planning teams, because tariff volatility can affect inventory policies and cross-border distribution agreements. Overall, the cumulative impact of tariffs in 2025 served as a catalyst for greater vertical integration, nearshoring conversations, and enhanced focus on cost management across manufacturing and distribution nodes.

Deep segmentation-based insights revealing how product type, prescription modality, and age cohorts influence access, messaging, and channel strategy for emergency contraception

Insightful segmentation reveals differentiated demand drivers and access pathways that require tailored strategic responses. Based on Product Type, market dynamics differ among Levonorgestrel, Mifepristone, and Ulipristal Acetate in terms of clinical indications, dosing windows, and regulatory status, which in turn influences labeling, consumer guidance, and distribution choices. Based on Prescription Type, the distinction between Over The Counter and Prescription availability shapes channel strategy, patient counseling requirements, and payer interactions, with OTC pathways demanding robust point-of-sale education and prescription routes requiring integrated clinician engagement.

Age-related segmentation also informs targeted outreach and packaging: Based on Age Group, the cohorts 15-19 Years, 20-24 Years, 25-29 Years, and 30 Years And Above display varying health literacy, purchasing preferences, and privacy expectations. Younger cohorts tend to favor digital-first information channels and discreet fulfillment options, whereas older cohorts may prioritize in-person clinical reassurance and broader product information. Together, these segmentation lenses provide an actionable framework for product managers and patient engagement teams to design differentiated marketing, educational materials, and distribution partnerships that align with clinical constraints and consumer behavior.

Comparative regional perspectives highlighting how regulatory frameworks, cultural norms, and manufacturing footprints drive distinct access and distribution strategies worldwide

Regional dynamics shape regulatory approaches, supply chain architecture, and consumer access models in markedly different ways. In the Americas, policy debates and advocacy have accelerated moves toward broader access with a mix of OTC availability and telehealth services, leading to robust retail and e-commerce channels supported by established distribution networks. In contrast, Europe, Middle East & Africa presents a heterogeneous regulatory mosaic where national policies, cultural norms, and reimbursement systems result in varying access pathways, requiring regionally tailored regulatory strategies and stakeholder engagement plans.

Asia-Pacific combines high-volume manufacturing capabilities with rapidly evolving digital health adoption; this region is simultaneously a major production base and a dynamic market for consumer-facing distribution innovations. These regional variances necessitate differentiated commercial playbooks, where regulatory intelligence, local partnerships, and culturally attuned communication are essential to navigate policy nuance and to optimize product positioning across jurisdictions.

Competitive company behaviors and strategic priorities showing how manufacturers, generics, and digital entrants are shaping product access and distribution ecosystems

Key companies active in emergency contraceptive pills are pursuing strategies that reflect portfolio depth, channel reach, and manufacturing capabilities. Established pharmaceutical manufacturers leverage scale, regulatory experience, and legacy relationships with wholesalers to maintain broad distribution, while generics producers focus on cost efficiency and rapid product launches where regulatory pathways permit. Emerging players, including specialized biotech and digital health platforms, concentrate on differentiated service models that combine telehealth prescribing with integrated fulfillment and consumer education.

Strategic moves observed across company types include investments in formulation enhancements, partnerships with pharmacy chains and online platforms, and selective regional capacity expansions to mitigate trade-related risks. Companies that prioritize cross-functional coordination between clinical affairs, regulatory teams, and commercial units tend to accelerate time-to-market for label updates and channel transitions. Competitive advantage increasingly depends on the ability to balance regulatory compliance, rapid access, and consumer-centric design while protecting margins through operational efficiency and supply chain resilience.

Actionable recommendations for leaders to strengthen supply resilience, expand digital access, and align regulatory strategy with consumer-centered commercialization

Industry leaders should adopt pragmatic measures that balance access, safety, and commercial sustainability. First, diversify supplier networks and invest in supplier qualification to reduce exposure to single-source risks exacerbated by trade policy fluctuations; this includes building regional manufacturing capacity or securing long-term supply agreements. Second, integrate telehealth partnerships and digital commerce capabilities into omnichannel strategies to ensure timely access and to reach cohorts that prioritize privacy and convenience.

Third, align regulatory affairs with commercial planning to expedite label clarifications and OTC transitions where clinically appropriate, while ensuring that product labeling and packaging address real-world use considerations. Fourth, invest in targeted education campaigns that resonate with distinct age cohorts and clinical audiences to reduce misuse and to improve time-to-treatment. Finally, implement advanced inventory and demand sensing practices to maintain service levels during policy-driven supply disruptions, and embed scenario planning into strategic reviews to respond swiftly to evolving trade and regulatory conditions.

A transparent methodological overview describing evidence sources, stakeholder consultations, and scenario-driven analysis used to derive insights and strategic implications

This analysis synthesizes regulatory filings, clinical guidance updates, supply chain trend reporting, and public domain policy announcements to triangulate actionable insights. Primary inputs included regulatory decisions and guidance documents, trade policy notices, and anonymized industry interviews with supply chain and commercial leaders, which together informed interpretation of distribution and sourcing strategies. Secondary inputs encompassed peer-reviewed clinical literature on efficacy windows and safety profiles, as well as aggregated digital health adoption indicators to contextualize changes in patient access channels.

Analytical methods combined qualitative synthesis with scenario-based impact assessment to evaluate implications of policy shifts, supply chain disruptions, and channel evolution. Cross-validation was performed by comparing independent sources and practitioner perspectives to ensure consistency and to surface areas of divergence that warrant closer monitoring. Ethical considerations and patient safety remained central throughout the methodology, and wherever applicable, clinical evidence was cross-checked against authoritative guidance documents to maintain accuracy and relevance.

A conclusive synthesis emphasizing resilience, regulatory alignment, and patient-centered strategies as the pillars for reliable emergency contraceptive access

Emergency contraceptive pills occupy a unique intersection of clinical urgency, policy sensitivity, and consumer preference, creating both opportunities and responsibilities for stakeholders. As regulatory frameworks and digital channels continue to evolve, the most successful organizations will be those that can rapidly translate clinical evidence into safe access pathways while maintaining supply chain robustness and culturally competent communication. The interplay between trade policy, manufacturing locus, and distribution networks underscores the importance of flexibility in sourcing and the value of local partnerships to sustain access under shifting conditions.

Moving forward, decision makers should prioritize interoperability across regulatory, commercial, and clinical domains to respond quickly to changes in policy or public health guidance. By focusing on resilience, consumer-focused design, and regulatory alignment, stakeholders can responsibly expand access while safeguarding product quality and patient outcomes. The strategic choices made now will determine who can reliably deliver timely, safe emergency contraception in a landscape defined by rapid change and heightened public attention.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Telehealth platforms expanding nationwide prescription and doorstep delivery of emergency contraceptive pills
  • 5.2. Introduction of ulipristal acetate generics reshaping competitive pricing dynamics in key markets
  • 5.3. Rising Gen Z social media advocacy driving awareness and accessibility of emergency contraception
  • 5.4. Post-Dobbs policy shifts influencing over-the-counter emergency contraceptive availability and pricing
  • 5.5. Integration of emergency contraceptives into digital health apps for personalized postcoital guidance
  • 5.6. Growing environmental concerns over hormone residues spurring eco-friendly packaging innovations
  • 5.7. E-commerce penetration by Amazon Pharmacy and online retailers boosting on-demand pill purchases

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Emergency Contraceptive Pills Market, by Product Type

  • 8.1. Levonorgestrel
  • 8.2. Mifepristone
  • 8.3. Ulipristal Acetate

9. Emergency Contraceptive Pills Market, by Prescription Type

  • 9.1. Over The Counter
  • 9.2. Prescription

10. Emergency Contraceptive Pills Market, by Age Group

  • 10.1. 15-19 Years
  • 10.2. 20-24 Years
  • 10.3. 25-29 Years
  • 10.4. 30 Years And Above

11. Emergency Contraceptive Pills Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Emergency Contraceptive Pills Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Emergency Contraceptive Pills Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. Bayer AG
    • 14.3.2. Teva Pharmaceutical Industries Ltd
    • 14.3.3. Viatris Inc
    • 14.3.4. Cipla Ltd
    • 14.3.5. Dr. Reddy's Laboratories Ltd
    • 14.3.6. Lupin Ltd
    • 14.3.7. Sandoz International GmbH
    • 14.3.8. Perrigo Company plc
    • 14.3.9. Glenmark Pharmaceuticals Ltd
    • 14.3.10. Apotex Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. LATIN AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. MIDDLE EAST EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASEAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GCC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPEAN UNION EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. BRICS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. G7 EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. NATO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. EMERGENCY CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. EMERGENCY CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. EMERGENCY CONTRACEPTIVE PILLS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY LEVONORGESTREL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY LEVONORGESTREL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY LEVONORGESTREL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY LEVONORGESTREL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY LEVONORGESTREL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY LEVONORGESTREL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY MIFEPRISTONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY MIFEPRISTONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY MIFEPRISTONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY MIFEPRISTONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY MIFEPRISTONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY MIFEPRISTONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY ULIPRISTAL ACETATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY ULIPRISTAL ACETATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY ULIPRISTAL ACETATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY ULIPRISTAL ACETATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY ULIPRISTAL ACETATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY ULIPRISTAL ACETATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY OVER THE COUNTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY OVER THE COUNTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY OVER THE COUNTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY OVER THE COUNTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 15-19 YEARS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 15-19 YEARS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 15-19 YEARS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 15-19 YEARS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 15-19 YEARS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 15-19 YEARS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 20-24 YEARS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 20-24 YEARS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 20-24 YEARS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 20-24 YEARS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 20-24 YEARS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 20-24 YEARS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 25-29 YEARS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 25-29 YEARS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 25-29 YEARS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 25-29 YEARS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 25-29 YEARS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 25-29 YEARS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 30 YEARS AND ABOVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 30 YEARS AND ABOVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 30 YEARS AND ABOVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 30 YEARS AND ABOVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 30 YEARS AND ABOVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 30 YEARS AND ABOVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 68. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 69. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 70. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 71. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 72. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 73. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 78. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 80. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. LATIN AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 86. LATIN AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 88. LATIN AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. LATIN AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 102. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 103. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 104. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 105. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. MIDDLE EAST EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 110. MIDDLE EAST EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 112. MIDDLE EAST EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. MIDDLE EAST EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 118. AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 119. AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 120. AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 121. AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. ASEAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. ASEAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. ASEAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. ASEAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 137. ASEAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 138. ASEAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 139. ASEAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. ASEAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GCC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GCC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GCC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. GCC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 145. GCC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. GCC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. GCC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GCC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPEAN UNION EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPEAN UNION EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPEAN UNION EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPEAN UNION EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. BRICS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. BRICS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. BRICS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. BRICS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. BRICS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. BRICS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 163. BRICS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. BRICS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. G7 EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. G7 EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. G7 EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 168. G7 EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 169. G7 EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. G7 EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. G7 EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. G7 EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. NATO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. NATO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. NATO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. NATO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. NATO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. NATO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. NATO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. NATO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 187. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 191. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 193. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 266. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 267. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 272. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 273. EMERGENCY CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 274. EMERGENCY CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2024